01st September 2022 – CRI Report

ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET 2022-2028

admin — Tue, 06 Dec 2022 10:23:41 +0000

MARKET OUTLOOK

CRI’s research report suggests that the Asia-Pacific companion diagnostics market is anticipated to showcase a CAGR of 13.10% during the forecasted years 2022-2028. China, India, Australia & New Zealand, Japan, ASEAN countries, South Korea, and Rest of Asia-Pacific are considered in the region.
India is considered a major emerging genomics market, with oncologists accepting biomarker-based tests. The rising middle-class healthcare facilities and skilled practitioners have driven the expansion of clinical diagnostics in the country. Besides this, government hospitals like AIIMS and NIMHANS are striving to identify new disease genes and biomarkers. Therefore, these factors are expected to fuel the development of the companion diagnostics market across India over the forecast period.
In South Korea, the public healthcare system is offered to all citizens through the National Health Insurance Corporation under the Ministry of Health and Wellness. As per WHO, the Ministry is in charge of policies and supervision of the healthcare systems. In this regard, the Health Insurance Review Agency reviews medical charges, evaluating the overall healthcare system. The overall development of the healthcare system supports the demand for companion diagnostics tests, driving the South Korean market’s growth.

COMPETITIVE OUTLOOK

The leading companies in the companion diagnostics market include Almac Group, Biocartis, Abbott Laboratories, Arup Laboratories, GE Healthcare, and Qiagen.

1. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE COMPANION DIAGNOSTICS MARKET
2.2. KEY INSIGHTS
2.2.1. COMMERCIAL SUCCESS OF PRECISION MEDICINE TREATMENT
2.2.2. ADOPTION OF PREDICTIVE BIOMARKERS
2.2.3. FUSION OF COMPUTER SCIENCE AND BIOLOGY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. COST
2.4.2. AVAILABILITY
2.4.3. SENSITIVITY & SPECIFICITY
2.4.4. EFFICACY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT LAUNCHES
2.9.3. CONTRACTS & AGREEMENTS
2.10. MARKET DRIVERS
2.10.1. INCREASE IN INCIDENCE OF MEDICATION REACTIONS
2.10.2. INCREASING PREVALENCE OF CANCER CASES AND FATALITIES
2.10.3. RISING PREVALENCE OF PRECISION MEDICINES
2.11. MARKET CHALLENGES
2.11.1. WEAK REIMBURSEMENT FRAMEWORK
2.11.2. COMMON CASES OF LEAKAGE IN ONCOLOGY COMPANION DIAGNOSTICS
2.12. MARKET OPPORTUNITY
2.12.1. ONGOING RESEARCH AND INVESTMENTS IN NEXT GENERATION GENE-SEQUENCING
3. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET OUTLOOK – BY MECHANISM
3.1. IN-SITU HYBRIDIZATION
3.2. POLYMERASE CHAIN REACTION
3.3. IMMUNOHISTOCHEMISTRY
3.4. NEXT GENERATION SEQUENCING
3.5. OTHER MECHANISMS
4. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET OUTLOOK – BY INDICATOR
4.1. ONCOLOGY
4.2. NEUROLOGY
4.3. INFECTIOUS DISEASES
4.4. OTHER INDICATORS
5. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET OUTLOOK – BY CONSUMER
5.1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
5.2. REFERENCE LABORATORIES
5.3. OTHER CONSUMERS
6. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET OUTLOOK – BY COMMODITY
6.1. ASSAY KITS AND REAGENTS
6.2. SOFTWARE AND SERVICES
7. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET – COUNTRY OUTLOOK
7.1. CHINA
7.2. JAPAN
7.3. INDIA
7.4. SOUTH KOREA
7.5. ASEAN COUNTRIES
7.6. AUSTRALIA & NEW ZEALAND
7.7. REST OF ASIA-PACIFIC
8. COMPETITIVE LANDSCAPE
8.1. ABBOTT LABORATORIES
8.2. ALMAC GROUP
8.3. ARUP LABORATORIES
8.4. BIOCARTIS
8.5. BIOMERIEUX
8.6. DANAHER CORPORATION
8.7. GE HEALTHCARE
8.8. GENOMIC HEALTH
8.9. ILLUMINA INC
8.10. MYRIAD GENETICS
8.11. QIAGEN
8.12. ROCHE DIAGNOSTICS
8.13. SYSMEX CORPORATION
8.14. THERMO FISHER SCIENTIFIC
8.15. AGILENT
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

LIST OF TABLES

TABLE 1: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF CONTRACTS & AGREEMENTS
TABLE 6: NUMBER OF CANCER PATIENTS IN 2020
TABLE 7: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2022-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2022-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2022-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2022-2028 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: INDUSTRY COMPONENTS
FIGURE 3: FDA FRAMEWORK
FIGURE 4: CDX LEAKAGE POINTS
FIGURE 5: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2021 & 2028 (IN %)
FIGURE 6: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY IN-SITU HYBRIDIZATION, 2022-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY POLYMERASE CHAIN REACTION, 2022-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY IMMUNOHISTOCHEMISTRY, 2022-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY NEXT GENERATION SEQUENCING, 2022-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY OTHER MECHANISMS, 2022-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2021 & 2028 (IN %)
FIGURE 12: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY ONCOLOGY, 2022-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY NEUROLOGY, 2022-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY INFECTIOUS DISEASES, 2022-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY OTHER INDICATORS, 2022-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2021 & 2028 (IN %)
FIGURE 17: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY REFERENCE LABORATORIES, 2022-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY OTHER CONSUMERS, 2022-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2021 & 2028 (IN %)
FIGURE 21: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY ASSAY KITS AND REAGENTS, 2022-2028 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY SOFTWARE AND SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 24: CHINA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: JAPAN COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: INDIA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: SOUTH KOREA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 28: ASEAN COUNTRIES COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 29: AUSTRALIA & NEW ZEALAND COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 30: REST OF ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)

The post ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET 2022-2028 first appeared on CRI Report.

GLOBAL CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

admin — Tue, 06 Dec 2022 10:23:40 +0000

MARKET OUTLOOK

CRI’s report on the global cardiovascular ultrasound market, has insinuated that it would grow with a CAGR of 6.12% in the forecasted period 2022-2028.

The market is witnessing growth due to an increase in the number of people being affected by cardiovascular diseases, which has resulted in increased demand for echocardiography systems.

In addition to this, developments in technology are expected to support the market growth.
However, issues like lack of awareness among patients and the need for companies to adhere to stringent regulations & guidelines are significantly hampering this progress.

On the positive side, the growth of the fetal echocardiography segment and the rising adoption of point-of-care ultrasound systems are also offering lucrative opportunities for the studied market’s growth.

REGIONAL OUTLOOK

The global cardiovascular ultrasound market spans across North America, the Asia-Pacific, Latin America, Europe, and the Middle East and Africa.
The market in the Asia-Pacific is anticipated to showcase the fastest growth globally, over the considered period. Factors such as continual advances in technology have had a positive impact on the field of cardiology. They have led to the development of diagnostic methodologies for certain heart conditions. This, in turn, has boosted the demand for electrocardiography systems, thus bolstering the market growth in the region.

COMPETITIVE OUTLOOK

The key players profiled in the cardiovascular ultrasound market report include Telemed Ultrasound Medical Systems, Esaote S.p.A., GE Healthcare, Philips Healthcare, Samsung Medison Co Ltd, Viatom Technology Co, Dawei Medical, Canon Medical Corp, Leltek Inc, Lanmage, Siemens Healthineers, Clarius, Zoncare, Fujifilm Holdings Corporation, and Mindray Medical International Limited.

Canon Medical Corp is a renowned name in the field of healthcare, and is recognized as one of the world’s top diagnostic imaging equipment providers. It offers a full range of solutions for diagnostic medical imaging, such as X-rays, CT scans, MRI scans, ultrasound, and healthcare informatics.

The corporation offers electrocardiography equipment under its Aplio i-series and Xario g-series product ranges. It specializes in the areas of cardiology, oncology, sports medicine, artificial intelligence, and collaborative imaging. It has a business presence in North America, Europe, the Asia-Pacific, and Latin America. Founded in 1948, Canon Medical has a strong workforce of over 5000 employees globally,

1. GLOBAL CARDIOVASCULAR ULTRASOUND MARKET – SUMMARY

2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CARDIOVASCULAR ULTRASOUND MARKET
2.2. KEY INSIGHTS
2.2.1. EMERGENCE OF ARTIFICIAL INTELLIGENCE (AI)
2.2.2. STRAIN IMAGING HAS SEEN A GRADUAL INCREASE
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. DURABILITY
2.4.3. PRICE
2.4.4. TECHNOLOGY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. PRODUCT LAUNCHES
2.9.2. ALLIANCES
2.10. MARKET DRIVERS
2.10.1. INCREASE IN CARDIOVASCULAR DISEASE CASES
2.10.2. ADVANCEMENTS IN TECHNOLOGY
2.11. MARKET CHALLENGES
2.11.1. LACK OF AWARENESS AMONG PATIENTS
2.11.2. NEED TO ABIDE BY STRINGENT REGULATIONS
2.12. MARKET OPPORTUNITIES
2.12.1. RAPID EXPANSION OF POINT-OF-CARE ULTRASOUND (POCUS)
2.12.2. GROWING CARDIOVASCULAR ULTRASOUND MARKET IN THE ASIA- REGION
2.12.3. RAPID GROWTH OF FETAL ECHOCARDIOGRAPHY

3. GLOBAL CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY DISPLAY
3.1. BLACK AND WHITE
3.2. COLORED

4. GLOBAL CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TECHNOLOGY
4.1. 2D
4.2. 3D/4D
4.3. DOPPLER

5. GLOBAL CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TYPE
5.1. TRANSTHORACIC ECHOCARDIOGRAPHY
5.2. FETAL ECHOCARDIOGRAPHY
5.3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY
5.4. OTHER TYPES

6. GLOBAL CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS
6.2. DIAGNOSTIC CENTERS
6.3. AMBULATORY CARE CENTERS
6.4. OTHER END-USERS

7. GLOBAL CARDIOVASCULAR ULTRASOUND MARKET – REGIONAL OUTLOOK
7.1. NORTH AMERICA
7.1.1. MARKET BY DISPLAY
7.1.2. MARKET BY TECHNOLOGY
7.1.3. MARKET BY TYPE
7.1.4. MARKET BY END-USER
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET BY DISPLAY
7.2.2. MARKET BY TECHNOLOGY
7.2.3. MARKET BY TYPE
7.2.4. MARKET BY END-USER
7.2.5. COUNTRY ANALYSIS
7.2.5.1. UNITED KINGDOM
7.2.5.2. GERMANY
7.2.5.3. FRANCE
7.2.5.4. SPAIN
7.2.5.5. ITALY
7.2.5.6. REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET BY DISPLAY
7.3.2. MARKET BY TECHNOLOGY
7.3.3. MARKET BY TYPE
7.3.4. MARKET BY END-USER
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. INDIA
7.3.5.4. SOUTH KOREA
7.3.5.5. ASEAN COUNTRIES
7.3.5.6. AUSTRALIA & NEW ZEALAND
7.3.5.7. REST OF ASIA-PACIFIC
7.4. LATIN AMERICA
7.4.1. MARKET BY DISPLAY
7.4.2. MARKET BY TECHNOLOGY
7.4.3. MARKET BY TYPE
7.4.4. MARKET BY END-USER
7.4.5. COUNTRY ANALYSIS
7.4.5.1. BRAZIL
7.4.5.2. MEXICO
7.4.5.3. REST OF LATIN AMERICA
7.5. MIDDLE EAST AND AFRICA
7.5.1. MARKET BY DISPLAY
7.5.2. MARKET BY TECHNOLOGY
7.5.3. MARKET BY TYPE
7.5.4. MARKET BY END-USER
7.5.5. COUNTRY ANALYSIS
7.5.5.1. UNITED ARAB EMIRATES
7.5.5.2. SAUDI ARABIA
7.5.5.3. TURKEY
7.5.5.4. SOUTH AFRICA
7.5.5.5. REST OF MIDDLE EAST & AFRICA

8. COMPETITIVE LANDSCAPE
8.1. GE HEALTHCARE
8.2. PHILIPS HEALTHCARE
8.3. SIEMENS HEALTHINEERS
8.4. CANON MEDICAL CORP
8.5. FUJIFILM HOLDINGS CORPORATION
8.6. SAMSUNG MEDISON CO LTD
8.7. ESAOTE S.P.A.
8.8. MINDRAY MEDICAL INTERNATIONAL LIMITED
8.9. VIATOM TECHNOLOGY CO
8.10. LANMAGE
8.11. DAWEI MEDICAL
8.12. ZONCARE
8.13. LELTEK INC
8.14. TELEMED ULTRASOUND MEDICAL SYSTEMS
8.15. CLARIUS

9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF ALLIANCES
TABLE 6: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028, (IN $ MILLION)
TABLE 7: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028, (IN $ MILLION)
TABLE 8: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028, (IN $ MILLION)
TABLE 9: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028, (IN $ MILLION)
TABLE 10: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY REGIONAL OUTLOOK, 2022-2028, (IN $ MILLION)
TABLE 11: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 16: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 17: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 18: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 19: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 20: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 23: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 24: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 25: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 26: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 27: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 28: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 29: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 30: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 31: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 32: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 33: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 34: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 35: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2021 & 2028 (IN %)
FIGURE 5: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2028 (IN $ MILLION)
FIGURE 6: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY COLORED, 2022-2028 (IN $ MILLION)
FIGURE 7: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2021 & 2028 (IN %)
FIGURE 8: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2028 (IN $ MILLION)
FIGURE 9: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2028 (IN $ MILLION)
FIGURE 10: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2028 (IN $ MILLION)
FIGURE 11: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 12: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 13: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 14: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 15: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 16: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 17: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 18: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 19: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 20: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 21: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, REGIONAL OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: UNITED STATES CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: CANADA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: UNITED KINGDOM CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: GERMANY CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: FRANCE CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: SPAIN CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 28: ITALY CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 29: REST OF EUROPE CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 30: CHINA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 31: JAPAN CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 32: INDIA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 33: SOUTH KOREA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 34: ASEAN COUNTRIES CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: AUSTRALIA & NEW ZEALAND CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 36: REST OF ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 37: BRAZIL CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 38: MEXICO CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: REST OF LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: UNITED ARAB EMIRATES CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: SAUDI ARABIA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: TURKEY CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 43: SOUTH AFRICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 44: REST OF MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)

The post GLOBAL CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 first appeared on CRI Report.

NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

admin — Tue, 06 Dec 2022 10:23:39 +0000

NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK

According to this report, North America’s cardiovascular ultrasound market is likely to develop with a CAGR of 5.38% in the projected duration between 2022 and 2028. The United States and Canada are analyzed in the market in this region.

Earlier, hospital admissions for cardiovascular diseases in Canada were significantly lesser. However, in recent years, hospitalizations for these ailments have risen significantly. Hospitalization rates for structural heart disease stood at 50%, and for heart failure stood at 35%. Thus, there has been a significant demand for efficient cardiovascular ultrasound systems to diagnose these illnesses in the earlier stages.

As a result, leading manufacturers are launching novel, technologically advanced products, which is expected to consolidate the market’s growth.

Heart diseases are a leading cause of death in the United States. Every year, close to 655,000 people in the country lose their lives to these ailments. Coronary heart disease (CHD) is the most common type of heart disease, which leads to nearly 366,000 deaths each year. Estimates suggest that 7.8% of adults in New York State reported having a heart attack, CHD, or stroke, in 2018.

These diseases are more common among the elderly. In the same year, 1 in every 5 New Yorkers aged 65 years or older (20%) reported being affected by some form of heart disease. The alarming prevalence of these conditions has accelerated the demand for cardiovascular ultrasound systems, which is expected to foster the market’s growth.

COMPETITIVE OUTLOOK

Leltek Inc, Telemed Ultrasound Medical Systems, Zoncare, Fujifilm Holdings Corporation, Clarius, Samsung Medison Co Ltd, Siemens Healthineers, and Esaote S.p.A. are some of the noteworthy players operating in the cardiovascular ultrasound market.

1. NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CARDIOVASCULAR ULTRASOUND MARKET
2.2. KEY INSIGHTS
2.2.1. EMERGENCE OF ARTIFICIAL INTELLIGENCE (AI)
2.2.2. STRAIN IMAGING HAS SEEN A GRADUAL INCREASE
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. DURABILITY
2.4.3. PRICE
2.4.4. TECHNOLOGY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. PRODUCT LAUNCHES
2.9.2. ALLIANCES
2.10. MARKET DRIVERS
2.10.1. INCREASE IN CARDIOVASCULAR DISEASE CASES
2.10.2. ADVANCEMENTS IN TECHNOLOGY
2.11. MARKET CHALLENGES
2.11.1. LACK OF AWARENESS AMONG PATIENTS
2.11.2. NEED TO ABIDE BY STRINGENT REGULATIONS
2.12. MARKET OPPORTUNITIES
2.12.1. RAPID EXPANSION OF POINT-OF-CARE ULTRASOUND (POCUS)
2.12.2. RAPID GROWTH OF FETAL ECHOCARDIOGRAPHY
3. NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY DISPLAY
3.1. BLACK AND WHITE
3.2. COLORED
4. NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TECHNOLOGY
4.1. 2D
4.2. 3D/4D
4.3. DOPPLER
5. NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TYPE
5.1. TRANSTHORACIC ECHOCARDIOGRAPHY
5.2. FETAL ECHOCARDIOGRAPHY
5.3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY
5.4. OTHER TYPES
6. NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS
6.2. DIAGNOSTIC CENTERS
6.3. AMBULATORY CARE CENTERS
6.4. OTHER END-USERS
7. NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET – COUNTRY OUTLOOK
7.1. UNITED STATES
7.2. CANADA
8. COMPETITIVE LANDSCAPE
8.1. GE HEALTHCARE
8.2. PHILIPS HEALTHCARE
8.3. SIEMENS HEALTHINEERS
8.4. CANON MEDICAL CORP
8.5. FUJIFILM HOLDINGS CORPORATION
8.6. SAMSUNG MEDISON CO LTD
8.7. ESAOTE S.P.A.
8.8. MINDRAY MEDICAL INTERNATIONAL LIMITED
8.9. VIATOM TECHNOLOGY CO
8.10. LANMAGE
8.11. DAWEI MEDICAL
8.12. ZONCARE
8.13. LELTEK INC
8.14. TELEMED ULTRASOUND MEDICAL SYSTEMS
8.15. CLARIUS
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF ALLIANCES
TABLE 6: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2021 & 2028 (IN %)
FIGURE 5: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COLORED, 2022-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2021 & 2028 (IN %)
FIGURE 8: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 12: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 17: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 19: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: UNITED STATES CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: CANADA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)

The post NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 first appeared on CRI Report.

MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

admin — Tue, 06 Dec 2022 10:23:38 +0000

MARKET OUTLOOK

CRI’s report on the cardiovascular ultrasound market in the Middle East and Africa puts forth that it would grow with a CAGR of 6.31% in the forecast period 2022-2028. Saudi Arabia, Turkey, the United Arab Emirates, South Africa, and Rest of Middle East & Africa are scrutinized in the market in this region.
According to estimates, cardiovascular disease (CVD) accounts for nearly 42% of all mortalities in Saudi Arabia. The risk factors for CVD can be classified into two sections: modifiable factors like obesity, hypertension, diabetes, dyslipidemia, and smoking, and non-modifiable factors like ethnicity, age, and family history.
A staggering 55.5% of the Saudi Arabian population is either hypertensive or pre-hypertensive; whereas, 20.2% of the population is diabetic. Awareness of CVD and its risk factors is critical in order to encourage people to adopt a healthier lifestyle. This, in turn, has boosted the use of cardiovascular ultrasound systems in the country, and is expected to drive the market growth in the forthcoming years.
At a mortality rate of 47%, cardiovascular disease accounts for nearly half of all deaths in Turkey. In 2020, close to 85,905 people lost their lives due to coronary heart disease in the country. However, Turkey has also been successful in managing these conditions by increasing the availability of percutaneous cardiac interventions for its citizens. This has promoted the adoption of echocardiography systems. The rising adoption is expected to lead the Turkish market on a growth path.

COMPETITIVE OUTLOOK

The notable players in the cardiovascular ultrasound market include Lanmage, Samsung Medison Co Ltd, Mindray Medical International Limited, Esaote S.p.A., Canon Medical Corp, GE Healthcare, Viatom Technology Co, and Philips Healthcare.

1. MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CARDIOVASCULAR ULTRASOUND MARKET
2.2. KEY INSIGHTS
2.2.1. EMERGENCE OF ARTIFICIAL INTELLIGENCE (AI)
2.2.2. STRAIN IMAGING HAS SEEN A GRADUAL INCREASE
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. DURABILITY
2.4.3. PRICE
2.4.4. TECHNOLOGY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. KEY MARKET STRATEGIES
2.8.1. PRODUCT LAUNCHES
2.8.2. ALLIANCES
2.9. MARKET DRIVERS
2.9.1. INCREASE IN CARDIOVASCULAR DISEASE CASES
2.9.2. ADVANCEMENTS IN TECHNOLOGY
2.10. MARKET CHALLENGES
2.10.1. LACK OF AWARENESS AMONG PATIENTS
2.10.2. NEED TO ABIDE BY STRINGENT REGULATIONS
2.11. MARKET OPPORTUNITIES
2.11.1. RAPID EXPANSION OF POINT-OF-CARE ULTRASOUND (POCUS)
2.11.2. RAPID GROWTH OF FETAL ECHOCARDIOGRAPHY
3. MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY DISPLAY
3.1. BLACK AND WHITE
3.2. COLORED
4. MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TECHNOLOGY
4.1. 2D
4.2. 3D/4D
4.3. DOPPLER
5. MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TYPE
5.1. TRANSTHORACIC ECHOCARDIOGRAPHY
5.2. FETAL ECHOCARDIOGRAPHY
5.3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY
5.4. OTHER TYPES
6. MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS
6.2. DIAGNOSTIC CENTERS
6.3. AMBULATORY CARE CENTERS
6.4. OTHER END-USERS
7. MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET – COUNTRY OUTLOOK
7.1. UNITED ARAB EMIRATES
7.2. SAUDI ARABIA
7.3. TURKEY
7.4. SOUTH AFRICA
7.5. REST OF MIDDLE EAST & AFRICA
8. COMPETITIVE LANDSCAPE
8.1. GE HEALTHCARE
8.2. PHILIPS HEALTHCARE
8.3. SIEMENS HEALTHINEERS
8.4. CANON MEDICAL CORP
8.5. FUJIFILM HOLDINGS CORPORATION
8.6. SAMSUNG MEDISON CO LTD
8.7. ESAOTE S.P.A.
8.8. MINDRAY MEDICAL INTERNATIONAL LIMITED
8.9. VIATOM TECHNOLOGY CO
8.10. LANMAGE
8.11. DAWEI MEDICAL
8.12. ZONCARE
8.13. LELTEK INC
8.14. TELEMED ULTRASOUND MEDICAL SYSTEMS
8.15. CLARIUS
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF PRODUCT LAUNCHES
TABLE 4: LIST OF ALLIANCES
TABLE 5: MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 6: MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 7: MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 8: MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2021 & 2028 (IN %)
FIGURE 5: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY COLORED, 2022-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2021 & 2028 (IN %)
FIGURE 8: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 12: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 17: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 21: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: UNITED ARAB EMIRATES CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: SAUDI ARABIA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: TURKEY CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: SOUTH AFRICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: REST OF MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)

The post MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 first appeared on CRI Report.

LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

admin — Tue, 06 Dec 2022 10:23:37 +0000

MARKET OUTLOOK

The cardiovascular ultrasound market in Latin America is predicted to showcase growth, with a CAGR of 6.41% during the forecast years between 2022 and 2028, according to this report. Mexico, Brazil, and Rest of Latin America are included in the market in this region.
Cardiovascular disease (CVD) incidence in the Mexican population is growing. In fact, cardiovascular disease mortality, as well as the prevalence of risk factors associated with the disease, have become significant causes of concern in Mexico. Thus, cardiovascular diseases and other non-communicable chronic diseases are becoming a growing burden as well as leading causes of disability among young adults.
The growing disease burden demands immediate attention, and the use of ultrasound systems for cardiovascular disease diagnosis will aid patients in seeking timely treatment. This, in turn, will foster the considered market’s growth. Even in Brazil, CVDs are a serious public health issue, as they are among the leading reasons for disability and mortality among adults, accounting for nearly 27.7% of total deaths.
The rising incidence of these diseases has a massive economic impact on the nation, leading to lost potential years of life and becoming a major burden on the public healthcare system, mainly in terms of expenditure. This makes it important to detect diseases on time, which can be done with the help of echocardiography systems. The adoption of these devices will aid the growth of the market in Brazil in the coming years.

COMPETITIVE OUTLOOK

The distinguished players operating in the cardiovascular ultrasound market include Viatom Technology Co, Lanmage, Fujifilm Holdings Corporation, Telemed Ultrasound Medical Systems, Samsung Medison Co Ltd, Dawei Medical, Mindray Medical International Limited, and Philips Healthcare.

1. LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CARDIOVASCULAR ULTRASOUND MARKET
2.2. KEY INSIGHTS
2.2.1. EMERGENCE OF ARTIFICIAL INTELLIGENCE (AI)
2.2.2. STRAIN IMAGING HAS SEEN A GRADUAL INCREASE
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. DURABILITY
2.4.3. PRICE
2.4.4. TECHNOLOGY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. KEY MARKET STRATEGIES
2.8.1. PRODUCT LAUNCHES
2.8.2. ALLIANCES
2.9. MARKET DRIVERS
2.9.1. INCREASE IN CARDIOVASCULAR DISEASE CASES
2.9.2. ADVANCEMENTS IN TECHNOLOGY
2.10. MARKET CHALLENGES
2.10.1. LACK OF AWARENESS AMONG PATIENTS
2.10.2. NEED TO ABIDE BY STRINGENT REGULATIONS
2.11. MARKET OPPORTUNITIES
2.11.1. RAPID EXPANSION OF POINT-OF-CARE ULTRASOUND (POCUS)
2.11.2. RAPID GROWTH OF FETAL ECHOCARDIOGRAPHY
3. LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY DISPLAY
3.1. BLACK AND WHITE
3.2. COLORED
4. LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TECHNOLOGY
4.1. 2D
4.2. 3D/4D
4.3. DOPPLER
5. LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TYPE
5.1. TRANSTHORACIC ECHOCARDIOGRAPHY
5.2. FETAL ECHOCARDIOGRAPHY
5.3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY
5.4. OTHER TYPES
6. LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS
6.2. DIAGNOSTIC CENTERS
6.3. AMBULATORY CARE CENTERS
6.4. OTHER END-USERS
7. LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET – COUNTRY OUTLOOK
7.1. BRAZIL
7.2. MEXICO
7.3. REST OF LATIN AMERICA
8. COMPETITIVE LANDSCAPE
8.1. GE HEALTHCARE
8.2. PHILIPS HEALTHCARE
8.3. SIEMENS HEALTHINEERS
8.4. CANON MEDICAL CORP
8.5. FUJIFILM HOLDINGS CORPORATION
8.6. SAMSUNG MEDISON CO LTD
8.7. ESAOTE S.P.A.
8.8. MINDRAY MEDICAL INTERNATIONAL LIMITED
8.9. VIATOM TECHNOLOGY CO
8.10. LANMAGE
8.11. DAWEI MEDICAL
8.12. ZONCARE
8.13. LELTEK INC
8.14. TELEMED ULTRASOUND MEDICAL SYSTEMS
8.15. CLARIUS
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF PRODUCT LAUNCHES
TABLE 4: LIST OF ALLIANCES
TABLE 5: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 6: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 7: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 8: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2021 & 2028 (IN %)
FIGURE 5: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COLORED, 2022-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2021 & 2028 (IN %)
FIGURE 8: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 12: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 14: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 15: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 16: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 17: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 18: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 19: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 20: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 21: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: BRAZIL CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: MEXICO CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: REST OF LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)

The post LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 first appeared on CRI Report.

EUROPE CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

admin — Tue, 06 Dec 2022 10:23:36 +0000

EUROPE CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK

CRI’s report on Europe’s cardiovascular ultrasound market estimates that it would grow in terms of revenue, with a CAGR of 6.03% in the forecast period from 2022 to 2028. Spain, Germany, France, Italy, the United Kingdom, and Rest of Europe are assessed in the market in this region.
Heart and circulatory diseases are responsible for nearly 25% of all deaths in the United Kingdom.

Approximately 7.6 million individuals (4 million men and 3.6 million women) in the nation have reported having a heart or circulatory disease. The most common type of heart disease is coronary heart disease (CHD). It is a leading cause of cardiac arrests and resulting mortality in both men and women.

The alarming prevalence rate of these diseases has enhanced the demand for cardiovascular ultrasound devices in the UK. This has prompted key players, such as Siemens Healthineers, GE Healthcare, and others, to offer technologically advanced echocardiography machines to diagnose and examine these conditions efficiently.

CVDs are also becoming increasingly prevalent in France. These ailments are largely affecting the younger segments of the population, and are the second leading cause of mortality in the country, at present. According to the statistics, approximately 63,181 people in the nation died from (CHD) in 2020, accounting for 13.22% of total deaths.

This has accelerated the demand for cardiovascular ultrasound systems to effectively detect these illnesses on time and aid the treatment process. The increased adoption of these equipment is expected to foster the cardiovascular ultrasound market’s growth in the years to come.

COMPETITIVE OUTLOOK

A few eminent players in the cardiovascular ultrasound market include Telemed Ultrasound Medical Systems, Samsung Medison Co Ltd, Clarius, Esaote S.p.A., Viatom Technology Co, Fujifilm Holdings Corporation, Dawei Medical, and Lanmage.

1. EUROPE CARDIOVASCULAR ULTRASOUND MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CARDIOVASCULAR ULTRASOUND MARKET
2.2. KEY INSIGHTS
2.2.1. EMERGENCE OF ARTIFICIAL INTELLIGENCE (AI)
2.2.2. STRAIN IMAGING HAS SEEN A GRADUAL INCREASE
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. DURABILITY
2.4.3. PRICE
2.4.4. TECHNOLOGY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. KEY MARKET STRATEGIES
2.8.1. PRODUCT LAUNCHES
2.8.2. ALLIANCES
2.9. MARKET DRIVERS
2.9.1. INCREASE IN CARDIOVASCULAR DISEASE CASES
2.9.2. ADVANCEMENTS IN TECHNOLOGY
2.10. MARKET CHALLENGES
2.10.1. LACK OF AWARENESS AMONG PATIENTS
2.10.2. NEED TO ABIDE BY STRINGENT REGULATIONS
2.11. MARKET OPPORTUNITIES
2.11.1. RAPID EXPANSION OF POINT-OF-CARE ULTRASOUND (POCUS)
2.11.2. RAPID GROWTH OF FETAL ECHOCARDIOGRAPHY
3. EUROPE CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY DISPLAY
3.1. BLACK AND WHITE
3.2. COLORED
4. EUROPE CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TECHNOLOGY
4.1. 2D
4.2. 3D/4D
4.3. DOPPLER
5. EUROPE CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TYPE
5.1. TRANSTHORACIC ECHOCARDIOGRAPHY
5.2. FETAL ECHOCARDIOGRAPHY
5.3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY
5.4. OTHER TYPES
6. EUROPE CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS
6.2. DIAGNOSTIC CENTERS
6.3. AMBULATORY CARE CENTERS
6.4. OTHER END-USERS
7. EUROPE CARDIOVASCULAR ULTRASOUND MARKET – COUNTRY OUTLOOK
7.1. UNITED KINGDOM
7.2. GERMANY
7.3. FRANCE
7.4. SPAIN
7.5. ITALY
7.6. REST OF EUROPE
8. COMPETITIVE LANDSCAPE
8.1. GE HEALTHCARE
8.2. PHILIPS HEALTHCARE
8.3. SIEMENS HEALTHINEERS
8.4. CANON MEDICAL CORP
8.5. FUJIFILM HOLDINGS CORPORATION
8.6. SAMSUNG MEDISON CO LTD
8.7. ESAOTE S.P.A.
8.8. MINDRAY MEDICAL INTERNATIONAL LIMITED
8.9. VIATOM TECHNOLOGY CO
8.10. LANMAGE
8.11. DAWEI MEDICAL
8.12. ZONCARE
8.13. LELTEK INC
8.14. TELEMED ULTRASOUND MEDICAL SYSTEMS
8.15. CLARIUS
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF ALLIANCES
TABLE 6: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 7: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 8: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 9: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2021 & 2028 (IN %)
FIGURE 5: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2028 (IN $ MILLION)
FIGURE 6: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY COLORED, 2022-2028 (IN $ MILLION)
FIGURE 7: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2021 & 2028 (IN %)
FIGURE 8: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2028 (IN $ MILLION)
FIGURE 9: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2028 (IN $ MILLION)
FIGURE 10: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2028 (IN $ MILLION)
FIGURE 11: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 12: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 13: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 14: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 15: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 16: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 17: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 18: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 19: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 20: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 21: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: UNITED KINGDOM CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: GERMANY CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: FRANCE CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: SPAIN CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: ITALY CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: REST OF EUROPE CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)

The post EUROPE CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 first appeared on CRI Report.

ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

admin — Tue, 06 Dec 2022 10:23:35 +0000

ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK

A report by CRI depicts that the cardiovascular ultrasound market in the Asia-Pacific will advance with a CAGR of 6.83% over the projected duration between 2022 and 2028. India, Japan, China, Australia & New Zealand, ASEAN countries, South Korea, and Rest of Asia-Pacific are evaluated in the market in this region.

Since the past two decades, the number of patients suffering from heart failure in Japan has grown rapidly, and has become a crucial issue in the fields of medical practice and public health. As a result, the demand for electrocardiography devices to detect cardiovascular diseases on time has increased. Also, manufacturers are focusing on incorporating advanced technologies into ultrasound machines. These factors are fueling the studied market’s growth in Japan.

In India, non-communicable diseases, such as cardiovascular disease (CVD), cancer, and others, account for nearly 60% of all deaths. In fact, CVDs are now the leading cause of death among Indians. Some factors associated with the cardiovascular disease epidemic in the nation are particularly alarming, such as its rapid spread, disease onset at a young age, and the high mortality rate.

Cardiovascular ultrasound machines are thus witnessing high demand. Key players like Siemens Healthineers, Philips Healthcare, and others, are offering their products to meet the rising needs of the healthcare sector and to aid in timely disease detection & treatment. This, in turn, is expected to drive the market growth in the long run.

COMPETITIVE OUTLOOK

Some of the acclaimed players in the cardiovascular ultrasound market are Canon Medical Corp, Telemed Ultrasound Medical Systems, Samsung Medison Co Ltd, Lanmage, Esaote S.p.A., Dawei Medical, Siemens Healthineers, and Mindray Medical International Limited.

1. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CARDIOVASCULAR ULTRASOUND MARKET
2.2. KEY INSIGHTS
2.2.1. EMERGENCE OF ARTIFICIAL INTELLIGENCE (AI)
2.2.2. STRAIN IMAGING HAS SEEN A GRADUAL INCREASE
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. DURABILITY
2.4.3. PRICE
2.4.4. TECHNOLOGY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. PRODUCT LAUNCHES
2.9.2. ALLIANCES
2.10. MARKET DRIVERS
2.10.1. INCREASE IN CARDIOVASCULAR DISEASE CASES
2.10.2. ADVANCEMENTS IN TECHNOLOGY
2.11. MARKET CHALLENGES
2.11.1. LACK OF AWARENESS AMONG PATIENTS
2.11.2. NEED TO ABIDE BY STRINGENT REGULATIONS
2.12. MARKET OPPORTUNITIES
2.12.1. RAPID EXPANSION OF POINT-OF-CARE ULTRASOUND (POCUS)
2.12.2. GROWING CARDIOVASCULAR ULTRASOUND MARKET IN THE ASIA-PACIFIC REGION
2.12.3. RAPID GROWTH OF FETAL ECHOCARDIOGRAPHY
3. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY DISPLAY
3.1. BLACK AND WHITE
3.2. COLORED
4. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TECHNOLOGY
4.1. 2D
4.2. 3D/4D
4.3. DOPPLER
5. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TYPE
5.1. TRANSTHORACIC ECHOCARDIOGRAPHY
5.2. FETAL ECHOCARDIOGRAPHY
5.3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY
5.4. OTHER TYPES
6. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS
6.2. DIAGNOSTIC CENTERS
6.3. AMBULATORY CARE CENTERS
6.4. OTHER END-USERS
7. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET – COUNTRY OUTLOOK
7.1. CHINA
7.2. JAPAN
7.3. INDIA
7.4. SOUTH KOREA
7.5. ASEAN COUNTRIES
7.6. AUSTRALIA & NEW ZEALAND
7.7. REST OF ASIA-PACIFIC
8. COMPETITIVE LANDSCAPE
8.1. GE HEALTHCARE
8.2. PHILIPS HEALTHCARE
8.3. SIEMENS HEALTHINEERS
8.4. CANON MEDICAL CORP
8.5. FUJIFILM HOLDINGS CORPORATION
8.6. SAMSUNG MEDISON CO LTD
8.7. ESAOTE S.P.A.
8.8. MINDRAY MEDICAL INTERNATIONAL LIMITED
8.9. VIATOM TECHNOLOGY CO
8.10. LANMAGE
8.11. DAWEI MEDICAL
8.12. ZONCARE
8.13. LELTEK INC
8.14. TELEMED ULTRASOUND MEDICAL SYSTEMS
8.15. CLARIUS
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF PRODUCT LAUNCHES
TABLE 4: LIST OF ALLIANCES
TABLE 5: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2021 & 2028 (IN %)
FIGURE 5: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY COLORED, 2022-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2021 & 2028 (IN %)
FIGURE 8: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 12: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 17: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: CHINA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: JAPAN CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: INDIA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: SOUTH KOREA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: ASEAN COUNTRIES CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: AUSTRALIA & NEW ZEALAND CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 28: REST OF ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)

The post ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 first appeared on CRI Report.

GLOBAL SURGICAL RETRACTORS MARKET 2022-2028

admin — Tue, 06 Dec 2022 10:23:34 +0000

MARKET OUTLOOK

A report by CRI highlights that the global surgical retractors market is anticipated to surge at a CAGR of 6.01% during the forecast period 2022-2028.
Globally, the factors boosting the surgical retractors market are rising cardiovascular disease cases and growing musculoskeletal disorders. Several patients require medical care and surgery to overcome cardiovascular health conditions such as coronary heart disease, cerebrovascular diseases, and others. Such surgeries are critical and take long hours. In this case, retractors help the surgeons make incisions and open the cavity. On the contrary, the emergence of minimally invasive surgery is expected to hamper market growth. These surgeries are considered more advanced as they don’t cause unnecessary damage to the body. Since the use of retractors is limited in these surgeries, it can hamper the growth of the studied market.

REGIONAL OUTLOOK

The global surgical retractors market is studied across countries such as Asia-Pacific, North America, Middle East and Africa, Latin America, and Europe.
Globally, North America dominates the surgical retractors market and is expected to maintain its stronghold until 2028. The rise in surgical procedures contributes to the growth of the market. According to an industry source, an estimated 48.3 million surgical and nonsurgical procedures are performed annually in the United States. Furthermore, data from the Canadian Medical Protective Association (CMPA) puts forth that, more than 1 million surgical operations are conducted each year in Canada.

COMPETITIVE OUTLOOK

The dominant players in the market include B Braun Holding GmbH & Co KG, Becton Dickinson and Company, Terumo Corporation, Stryker Corporation, World Precision Instruments, Teleflex Inc, Globus Medical Inc, The Cooper Companies Inc, Thompson Surgical Instruments, Mediflex, Medtronic Plc, and Integra Life Sciences.
Founded in 1897, Becton, Dickinson and Company (BD) is a global medical technology company engaged in developing, manufacturing, and selling a broad range of medical supplies to healthcare institutions, life science researchers, physicians, clinical laboratories, the pharmaceutical industry and general public. The company has a wide business portfolio. It operates in three segments: BD Life Sciences, BD Medical, and BD Interventional. One of the products offered by the company is the Hibbs retractor, an orthopedic instrument. The company is headquartered in New Jersey, United States and operates in regions including North America, Europe, Asia-Pacific and the Rest of the World.

1. GLOBAL SURGICAL RETRACTORS MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE SURGICAL RETRACTORS MARKET
2.2. KEY INSIGHTS
2.2.1. SURGICAL RETRACTORS ACT AS AN IMPORTANT SURGICAL TOOL
2.2.2. WIDE APPLICATION AND VARIETY OF SURGICAL RETRACTORS
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. RISING NUMBER OF CARDIOVASCULAR DISEASE CASES
2.6.2. GROWING MUSCULOSKELETAL DISORDERS
2.7. MARKET CHALLENGES
2.7.1. EMERGENCE OF MINIMALLY INVASIVE SURGERY
2.8. MARKET OPPORTUNITIES
2.8.1. GROWING SURGICAL PROCEDURE REQUIREMENTS
2.8.2. RISING GERIATRIC POPULATION
3. GLOBAL SURGICAL RETRACTORS MARKET OUTLOOK – BY TYPE
3.1. HANDHELD RETRACTORS
3.2. SELF-RETAINING RETRACTORS
3.3. OTHER TYPES
4. GLOBAL SURGICAL RETRACTORS MARKET OUTLOOK – BY APPLICATION
4.1. OBSTETRICS & GYNECOLOGY
4.2. CARDIOTHORACIC SURGERY
4.3. GENERAL SURGERY
4.4. ORTHOPEDICS
4.5. NEUROSURGERY
4.6. OTHER APPLICATIONS
5. GLOBAL SURGICAL RETRACTORS MARKET OUTLOOK – BY END-USER
5.1. HOSPITALS
5.2. AMBULATORY CARE CENTERS
5.3. OTHER END-USERS
6. GLOBAL SURGICAL RETRACTORS MARKET – REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. MARKET BY TYPE
6.1.2. MARKET BY APPLICATION
6.1.3. MARKET BY END-USER
6.1.4. COUNTRY ANALYSIS
6.1.4.1. UNITED STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET BY TYPE
6.2.2. MARKET BY APPLICATION
6.2.3. MARKET BY END-USER
6.2.4. COUNTRY ANALYSIS
6.2.4.1. UNITED KINGDOM
6.2.4.2. GERMANY
6.2.4.3. FRANCE
6.2.4.4. ITALY
6.2.4.5. SPAIN
6.2.4.6. NORDIC COUNTRIES
6.2.4.7. REST OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET BY TYPE
6.3.2. MARKET BY APPLICATION
6.3.3. MARKET BY END-USER
6.3.4. COUNTRY ANALYSIS
6.3.4.1. CHINA
6.3.4.2. INDIA
6.3.4.3. JAPAN
6.3.4.4. SOUTH KOREA
6.3.4.5. ASEAN COUNTRIES
6.3.4.6. AUSTRALIA & NEW ZEALAND
6.3.4.7. REST OF ASIA-PACIFIC
6.4. LATIN AMERICA
6.4.1. MARKET BY TYPE
6.4.2. MARKET BY APPLICATION
6.4.3. MARKET BY END-USER
6.4.4. COUNTRY ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST OF LATIN AMERICA
6.5. MIDDLE EAST AND AFRICA
6.5.1. MARKET BY TYPE
6.5.2. MARKET BY APPLICATION
6.5.3. MARKET BY END-USER
6.5.4. COUNTRY ANALYSIS
6.5.4.1. UNITED ARAB EMIRATES
6.5.4.2. SAUDI ARABIA
6.5.4.3. ISRAEL
6.5.4.4. SOUTH AFRICA
6.5.4.5. REST OF MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE
7.1. BECTON DICKINSON AND COMPANY
7.2. TELEFLEX INC
7.3. B BRAUN HOLDING GMBH & CO KG
7.4. TERUMO CORPORATION
7.5. INTEGRA LIFE SCIENCES
7.6. GLOBUS MEDICAL INC
7.7. MEDTRONIC PLC
7.8. THE COOPER COMPANIES INC
7.9. STRYKER CORPORATION
7.10. THOMPSON SURGICAL INSTRUMENTS
7.11. MEDIFLEX
7.12. WORLD PRECISION INSTRUMENTS
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: GLOBAL SURGICAL RETRACTORS MARKET, BY REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: GLOBAL SURGICAL RETRACTORS MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 4: GLOBAL SURGICAL RETRACTORS MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 5: GLOBAL SURGICAL RETRACTORS MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 6: GLOBAL SURGICAL RETRACTORS MARKET, BY REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 11: EUROPE SURGICAL RETRACTORS MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 12: EUROPE SURGICAL RETRACTORS MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 13: EUROPE SURGICAL RETRACTORS MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 14: EUROPE SURGICAL RETRACTORS MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC SURGICAL RETRACTORS MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC SURGICAL RETRACTORS MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 17: ASIA-PACIFIC SURGICAL RETRACTORS MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 18: ASIA-PACIFIC SURGICAL RETRACTORS MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 19: LATIN AMERICA SURGICAL RETRACTORS MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 20: LATIN AMERICA SURGICAL RETRACTORS MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 21: LATIN AMERICA SURGICAL RETRACTORS MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 22: LATIN AMERICA SURGICAL RETRACTORS MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 23: MIDDLE EAST & AFRICA SURGICAL RETRACTORS MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 24: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 25: MIDDLE EAST & AFRICA SURGICAL RETRACTORS MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 26: MIDDLE EAST & AFRICA SURGICAL RETRACTORS MARKET, BY END-USER, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: GLOBAL SURGICAL RETRACTORS MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 3: GLOBAL SURGICAL RETRACTORS MARKET, BY HANDHELD RETRACTORS, 2022-2028 (IN $ MILLION)
FIGURE 4: GLOBAL SURGICAL RETRACTORS MARKET, BY SELF-RETAINING RETRACTORS, 2022-2028 (IN $ MILLION)
FIGURE 5: GLOBAL SURGICAL RETRACTORS MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 6: GLOBAL SURGICAL RETRACTORS MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 7: GLOBAL SURGICAL RETRACTORS MARKET, BY OBSTETRICS & GYNECOLOGY, 2022-2028 (IN $ MILLION)
FIGURE 8: GLOBAL SURGICAL RETRACTORS MARKET, BY CARDIOTHORACIC SURGERY, 2022-2028 (IN $ MILLION)
FIGURE 9: GLOBAL SURGICAL RETRACTORS MARKET, BY GENERAL SURGERY, 2022-2028 (IN $ MILLION)
FIGURE 10: GLOBAL SURGICAL RETRACTORS MARKET, BY ORTHOPEDICS, 2022-2028 (IN $ MILLION)
FIGURE 11: GLOBAL SURGICAL RETRACTORS MARKET, BY NEUROSURGERY, 2022-2028 (IN $ MILLION)
FIGURE 12: GLOBAL SURGICAL RETRACTORS MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 13: GLOBAL SURGICAL RETRACTORS MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 14: GLOBAL SURGICAL RETRACTORS MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 15: GLOBAL SURGICAL RETRACTORS MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 16: GLOBAL SURGICAL RETRACTORS MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 17: GLOBAL SURGICAL RETRACTORS MARKET, REGIONAL OUTLOOK, 2021 & 2028 (IN %)
FIGURE 18: UNITED STATES SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 19: CANADA SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 20: UNITED KINGDOM SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 21: GERMANY SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 22: FRANCE SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: ITALY SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: SPAIN SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: NORDIC COUNTRIES SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: REST OF EUROPE SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: CHINA SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 28: INDIA SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 29: JAPAN SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 30: SOUTH KOREA SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 31: ASEAN COUNTRIES SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 32: AUSTRALIA & NEW ZEALAND SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 33: REST OF ASIA-PACIFIC SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 34: BRAZIL SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: MEXICO SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 36: REST OF LATIN AMERICA SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 37: UNITED ARAB EMIRATES SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 38: SAUDI ARABIA SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: ISRAEL SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: SOUTH AFRICA SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: REST OF MIDDLE EAST & AFRICA SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)

The post GLOBAL SURGICAL RETRACTORS MARKET 2022-2028 first appeared on CRI Report.

NORTH AMERICA SURGICAL RETRACTORS MARKET 2022-2028

admin — Tue, 06 Dec 2022 10:23:33 +0000

MARKET OUTLOOK

As per this report, the surgical retractors market in North America is likely to propel with a CAGR of 5.55% in the forecasted period from 2022-2028. Canada and the United States are considered in the market in this region.
According to the Centers for Medicare & Medicaid Services, the United States comprises 6,214 hospitals and 5,905 ambulatory surgical centers. These centers are used to perform various surgical procedures every year, making them the largest buyers of surgical instruments. These end-users are important customers for market players and are anticipated to increase demand for surgical retractors.
According to the Canadian Medical Protective Association (CMPA), more than a million surgical procedures are conducted annually in Canada. However, the Canadian Institute for Health Information (CIHI) reports that hospitals in the country have performed 560,000 fewer procedures since the pandemic’s start. Although, it is anticipated that the numbers will return to pre-COVID levels. Cesarean section delivery, hip replacement surgery, knee replacement surgery etc., are some of the procedures performed in the country that require surgical retractors. Thus, all these factors are expected to grow market demand for retractors.

COMPETITIVE OUTLOOK

The established players in the surgical retractors market include Becton Dickinson and Company, B Braun Holding GmbH & Co KG, Stryker Corporation, Teleflex Inc, The Cooper Companies Inc, World Precision Instruments and Terumo Corporation.

1. NORTH AMERICA SURGICAL RETRACTORS MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE SURGICAL RETRACTORS MARKET
2.2. KEY INSIGHTS
2.2.1. SURGICAL RETRACTORS ACT AS AN IMPORTANT SURGICAL TOOL
2.2.2. WIDE APPLICATION AND VARIETY OF SURGICAL RETRACTORS
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. RISING NUMBER OF CARDIOVASCULAR DISEASE CASES
2.6.2. GROWING MUSCULOSKELETAL DISORDERS
2.7. MARKET CHALLENGES
2.7.1. EMERGENCE OF MINIMALLY INVASIVE SURGERY
2.8. MARKET OPPORTUNITIES
2.8.1. GROWING SURGICAL PROCEDURE REQUIREMENTS
2.8.2. RISING GERIATRIC POPULATION
3. NORTH AMERICA SURGICAL RETRACTORS MARKET OUTLOOK – BY TYPE
3.1. HANDHELD RETRACTORS
3.2. SELF-RETAINING RETRACTORS
3.3. OTHER TYPES
4. NORTH AMERICA SURGICAL RETRACTORS MARKET OUTLOOK – BY APPLICATION
4.1. OBSTETRICS & GYNECOLOGY
4.2. CARDIOTHORACIC SURGERY
4.3. GENERAL SURGERY
4.4. ORTHOPEDICS
4.5. NEUROSURGERY
4.6. OTHER APPLICATIONS
5. NORTH AMERICA SURGICAL RETRACTORS MARKET OUTLOOK – BY END-USER
5.1. HOSPITALS
5.2. AMBULATORY CARE CENTERS
5.3. OTHER END-USERS
6. NORTH AMERICA SURGICAL RETRACTORS MARKET – COUNTRY OUTLOOK
6.1. UNITED STATES
6.2. CANADA
7. COMPETITIVE LANDSCAPE
7.1. BECTON DICKINSON AND COMPANY
7.2. TELEFLEX INC
7.3. B BRAUN HOLDING GMBH & CO KG
7.4. TERUMO CORPORATION
7.5. INTEGRA LIFE SCIENCES
7.6. GLOBUS MEDICAL INC
7.7. MEDTRONIC PLC
7.8. THE COOPER COMPANIES INC
7.9. STRYKER CORPORATION
7.10. THOMPSON SURGICAL INSTRUMENTS
7.11. MEDIFLEX
7.12. WORLD PRECISION INSTRUMENTS
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 5: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 3: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY HANDHELD RETRACTORS, 2022-2028 (IN $ MILLION)
FIGURE 4: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY SELF-RETAINING RETRACTORS, 2022-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 7: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY OBSTETRICS & GYNECOLOGY, 2022-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY CARDIOTHORACIC SURGERY, 2022-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY GENERAL SURGERY, 2022-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY ORTHOPEDICS, 2022-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY NEUROSURGERY, 2022-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 14: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA SURGICAL RETRACTORS MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA SURGICAL RETRACTORS MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 18: UNITED STATES SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 19: CANADA SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)

The post NORTH AMERICA SURGICAL RETRACTORS MARKET 2022-2028 first appeared on CRI Report.

MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET 2022-2028

admin — Tue, 06 Dec 2022 10:23:32 +0000

MARKET OUTLOOK

An analysis by CRI states that the surgical retractors market in the Middle East and Africa is expected to progress with a 6.31% CAGR in the forecasting period 2022-2028. Israel, South Africa, the United Arab Emirates, Saudi Arabia, and Rest of Middle East and Africa are studied across the market in this region.
In Saudi Arabia, the healthcare sector continues to be a primary concern for the government, with the country accounting for 60% of the GCC nations’ healthcare expenditures. In the country, the Ministry of Health (MoH) governs all healthcare-related operations and services. Additionally, the centralized government procurement of pharmaceuticals, medical equipment and supplies for all public healthcare facilities is held by National Unified Company for Medical Supplies (NUPCO).
Therefore, it is anticipated that the government’s emphasis on the development of the healthcare sector would promote growth of the surgical retractors market in the country.
In South Africa, the market is driven by several factors, including rising government initiatives, increasing preference for early disease diagnosis, and availability of well-established healthcare infrastructure. The country’s government and other organizations are launching campaigns to raise awareness among cancer patients and other chronic disease sufferers about prompt diagnosis and treatment. Such programs aim to improve healthcare standards, which is expected to propel growth of the country’s market.

COMPETITIVE OUTLOOK

B Braun Holding GmbH & Co KG, Teleflex Inc, Stryker Corporation, World Precision Instruments, Globus Medical Inc, and Thompson Surgical Instruments are the key players in the surgical retractors market.

1. MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE SURGICAL RETRACTORS MARKET
2.2. KEY INSIGHTS
2.2.1. SURGICAL RETRACTORS ACT AS AN IMPORTANT SURGICAL TOOL
2.2.2. WIDE APPLICATION AND VARIETY OF SURGICAL RETRACTORS
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. RISING NUMBER OF CARDIOVASCULAR DISEASE CASES
2.6.2. GROWING MUSCULOSKELETAL DISORDERS
2.7. MARKET CHALLENGES
2.7.1. EMERGENCE OF MINIMALLY INVASIVE SURGERY
2.8. MARKET OPPORTUNITIES
2.8.1. GROWING SURGICAL PROCEDURE REQUIREMENTS
2.8.2. RISING GERIATRIC POPULATION
3. MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET OUTLOOK – BY TYPE
3.1. HANDHELD RETRACTORS
3.2. SELF-RETAINING RETRACTORS
3.3. OTHER TYPES
4. MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET OUTLOOK – BY APPLICATION
4.1. OBSTETRICS & GYNECOLOGY
4.2. CARDIOTHORACIC SURGERY
4.3. GENERAL SURGERY
4.4. ORTHOPEDICS
4.5. NEUROSURGERY
4.6. OTHER APPLICATIONS
5. MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET OUTLOOK – BY END-USER
5.1. HOSPITALS
5.2. AMBULATORY CARE CENTERS
5.3. OTHER END-USERS
6. MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET – COUNTRY OUTLOOK
6.1. UNITED ARAB EMIRATES
6.2. SAUDI ARABIA
6.3. ISRAEL
6.4. SOUTH AFRICA
6.5. REST OF MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE
7.1. BECTON DICKINSON AND COMPANY
7.2. TELEFLEX INC
7.3. B BRAUN HOLDING GMBH & CO KG
7.4. TERUMO CORPORATION
7.5. INTEGRA LIFE SCIENCES
7.6. GLOBUS MEDICAL INC
7.7. MEDTRONIC PLC
7.8. THE COOPER COMPANIES INC
7.9. STRYKER CORPORATION
7.10. THOMPSON SURGICAL INSTRUMENTS
7.11. MEDIFLEX
7.12. WORLD PRECISION INSTRUMENTS
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 4: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 5: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 6: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 3: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY HANDHELD RETRACTORS, 2022-2028 (IN $ MILLION)
FIGURE 4: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY SELF-RETAINING RETRACTORS, 2022-2028 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 7: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY OBSTETRICS & GYNECOLOGY, 2022-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY CARDIOTHORACIC SURGERY, 2022-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY GENERAL SURGERY, 2022-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY ORTHOPEDICS, 2022-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY NEUROSURGERY, 2022-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 14: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 17: MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 18: UNITED ARAB EMIRATES SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 19: SAUDI ARABIA SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 20: ISRAEL SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 21: SOUTH AFRICA SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)
FIGURE 22: REST OF MIDDLE EAST & AFRICA SURGICAL RETRACTORS MARKET 2022-2028 (IN $ MILLION)

The post MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET 2022-2028 first appeared on CRI Report.

01st September 2022 – CRI Report

ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET 2022-2028

MARKET OUTLOOK

COMPETITIVE OUTLOOK

TABLE OF CONTENTS

LIST OF TABLES

LIST OF FIGURES

GLOBAL CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

MARKET OUTLOOK

REGIONAL OUTLOOK

COMPETITIVE OUTLOOK

TABLE OF CONTENTS

TABLE LIST

FIGURE LIST

NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK

COMPETITIVE OUTLOOK

TABLE OF CONTENTS

TABLE LIST

FIGURE LIST

MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

MARKET OUTLOOK

COMPETITIVE OUTLOOK

TABLE OF CONTENTS

TABLE LIST

FIGURE LIST

LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

MARKET OUTLOOK

COMPETITIVE OUTLOOK

TABLE OF CONTENTS

TABLE LIST

FIGURE LIST

EUROPE CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

EUROPE CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK

COMPETITIVE OUTLOOK

TABLE OF CONTENTS

TABLE LIST

FIGURE LIST

ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK

COMPETITIVE OUTLOOK

TABLE OF CONTENTS

TABLE LIST

FIGURE LIST

GLOBAL SURGICAL RETRACTORS MARKET 2022-2028

MARKET OUTLOOK

REGIONAL OUTLOOK

COMPETITIVE OUTLOOK

TABLE OF CONTENTS

TABLE LIST

FIGURE LIST

NORTH AMERICA SURGICAL RETRACTORS MARKET 2022-2028

MARKET OUTLOOK

COMPETITIVE OUTLOOK

TABLE OF CONTENTS

TABLE LIST

FIGURE LIST

MIDDLE EAST AND AFRICA SURGICAL RETRACTORS MARKET 2022-2028

MARKET OUTLOOK

COMPETITIVE OUTLOOK

TABLE OF CONTENTS

TABLE LIST

FIGURE LIST